Darunavir Tablet
Product Images NDC 60687-808

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Darunavir (NDC 60687-808). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

600 mg Darunavir Tablet Blister (600 mg Darunavir Tablet Blister)

FDA Label Image

600 mg Darunavir Tablets Carton (600 mg Darunavir Tablets Carton)

600 mg Darunavir Tablets Carton (600 mg Darunavir Tablets Carton)
This is a description of a medication called Darunavir in tablet form. The tablets come in a pack of 30 (3 x 10) and contain Darunavir 600 mg. It is recommended to store the medication at 20-25°C (68-77°F). The text also provides instructions to avoid using the medication if the blister is torn or broken. The manufacturing and distribution information is also included.*
FDA Label Image

800 mg Darunavir Tablet Blister (800 mg Darunavir Tablet Blister)

FDA Label Image

800 mg Darunavir Tablets Carton (800 mg Darunavir Tablets Carton)

800 mg Darunavir Tablets Carton (800 mg Darunavir Tablets Carton)
This is a product information sheet for Darunavir tablets, with each film-coated tablet containing Darunavir Hydrate equivalent to 800 mg of Darunavir. The usual dosage instructions are advised to be seen in the full prescribing information. The tablets are to be stored within the temperature range of 20° to 25°C and must be protected from excursions between 15° to 30°C. The package contains 30 tablets and should only be used as prescribed. The tablets are distributed by American Health Packaging.*
FDA Label Image

Ahp80821

FDA Label Image

Ahp81921

FDA Label Image

Structural Formula (Structure)

FDA Label Image

Figure 1: Pharmacokinetic Results (within-subject Comparison) Of Total And Unbound Darunavir After Administration Of Darunavir/ritonavir At 600/100 mg Twice Daily Or 800/100 mg Once Daily As Part Of A (Fig 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.